Litigation Details for Gilead Sciences, Inc. v. Mylan Inc. (S.D.N.Y. 2014)
✉ Email this page to a colleague
Gilead Sciences, Inc. v. Mylan Inc. (S.D.N.Y. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-06-02 |
Court | District Court, S.D. New York | Date Terminated | 2014-06-27 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Joseph Sullivan |
Jury Demand | None | Referred To | |
Patents | 6,642,245; 6,703,396; 8,592,397 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Mylan Inc.
Biologic Drugs cited in Gilead Sciences, Inc. v. Mylan Inc.
Details for Gilead Sciences, Inc. v. Mylan Inc. (S.D.N.Y. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-06-02 | 2 | trademark Truvada®. 27. United States Patent No. 6,642,245 (“the ’245 Patent,” copy attached as Exhibit A), …assigned the ’397 Patent to Gilead. COUNT l Infringement of U.S. Patent No. 6,642,245 37. Plaintiffs … Action l. This is an action for patent infringement under the patent laws of the United States, Title… the United States Patent and Trademark Office on November 4, 2003. The ’245 Patent claims, inter alia…for Truvada®. 28. United States Patent No. 6,703,396 (“the ’396 Patent,” copy attached as Exhibit B), | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |